{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:47:49Z","timestamp":1776905269702,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015045","name":"Kaohsiung Armed Forces General Hospital","doi-asserted-by":"publisher","award":["KAFGH-D-109030"],"award-info":[{"award-number":["KAFGH-D-109030"]}],"id":[{"id":"10.13039\/501100015045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMTTH-111-R005"],"award-info":[{"award-number":["KMTTH-111-R005"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15804-x","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:25:32Z","timestamp":1773401132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High VRK2 expression level predicts unfavorable survival outcomes in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Chien-Han","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Lung","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhen-Hao","family":"Jhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Huei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tzu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Fa","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Lun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Chih","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"6","key":"15804_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"10192","key":"15804_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380.","journal-title":"Lancet"},{"issue":"12","key":"15804_CR3","doi-asserted-by":"publisher","first-page":"e0315380","DOI":"10.1371\/journal.pone.0315380","volume":"19","author":"SA Yeh","year":"2024","unstructured":"Yeh SA, Chiu LC, Lin HC, Li HJ, Lin SF, Su YC. Trends in the incidence of the Epstein-Barr virus-associated malignancies extranodal NK\/T-cell lymphoma and nasopharyngeal carcinoma in Taiwan. PLoS ONE. 2024;19(12):e0315380.","journal-title":"PLoS ONE"},{"issue":"9","key":"15804_CR4","doi-asserted-by":"publisher","first-page":"e0204568","DOI":"10.1371\/journal.pone.0204568","volume":"13","author":"HC Fan","year":"2018","unstructured":"Fan HC, Chen CY, Hsu YC, Chou RH, Teng CJ, Chiu CH, et al. Increased risk of incident nasopharyngeal carcinoma with exposure to air pollution. PLoS ONE. 2018;13(9):e0204568.","journal-title":"PLoS ONE"},{"key":"15804_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-030-22254-3_2","volume":"1164","author":"HM Lee","year":"2019","unstructured":"Lee HM, Okuda KS, Gonzalez FE, Patel V. Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol. 2019;1164:11\u201334.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"15804_CR6","first-page":"3687","volume":"15","author":"L Wu","year":"2018","unstructured":"Wu L, Li C, Pan L. Nasopharyngeal carcinoma: A review of current updates. Exp Ther Med. 2018;15(4):3687\u201392.","journal-title":"Exp Ther Med"},{"issue":"9","key":"15804_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaoncol.2020.1808","volume":"6","author":"R You","year":"2020","unstructured":"You R, Liu YP, Huang PY, Zou X, Sun R, He YX, et al. Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020;6(9):1345\u201352.","journal-title":"JAMA Oncol"},{"key":"15804_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2020.10.051","volume":"498","author":"LX Peng","year":"2021","unstructured":"Peng LX, Wang MD, Xie P, Yang JP, Sun R, Zheng LS, et al. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3\/EGFR-ERK signaling resulting in unfavorable patient survival. Cancer Lett. 2021;498:165\u201377.","journal-title":"Cancer Lett"},{"key":"15804_CR9","doi-asserted-by":"publisher","first-page":"1116143","DOI":"10.3389\/fmicb.2023.1116143","volume":"14","author":"ZY Su","year":"2023","unstructured":"Su ZY, Siak PY, Leong CO, Cheah SC. The role of Epstein-Barr virus in nasopharyngeal carcinoma. Front Microbiol. 2023;14:1116143.","journal-title":"Front Microbiol"},{"issue":"2","key":"15804_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<241::AID-JMV11>3.0.CO;2-2","volume":"61","author":"MY Liu","year":"2000","unstructured":"Liu MY, Shih YY, Li LY, Chou SP, Sheen TS, Chen CL, et al. Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue. J Med Virol. 2000;61(2):241\u201350.","journal-title":"J Med Virol"},{"issue":"6","key":"15804_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/15548627.2020.1758416","volume":"17","author":"G Vilmen","year":"2021","unstructured":"Vilmen G, Glon D, Siracusano G, Lussignol M, Shao Z, Hernandez E, et al. BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction. Autophagy. 2021;17(6):1296\u2013315.","journal-title":"Autophagy"},{"issue":"9","key":"15804_CR12","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1021\/acsmedchemlett.9b00082","volume":"10","author":"RAM Serafim","year":"2019","unstructured":"Serafim RAM, de Souza Gama FH, Dutra LA, Dos Reis CV, Vasconcelos SNS, da Silva Santiago A, et al. Development of Pyridine-based Inhibitors for the Human Vaccinia-related Kinases 1 and 2. ACS Med Chem Lett. 2019;10(9):1266\u201371.","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"15804_CR13","first-page":"749","volume":"24","author":"EP Klerkx","year":"2009","unstructured":"Klerkx EP, Lazo PA, Askjaer P. Emerging biological functions of the vaccinia-related kinase (VRK) family. Histol Histopathol. 2009;24(6):749\u201359.","journal-title":"Histol Histopathol"},{"issue":"2","key":"15804_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/geno.1997.4938","volume":"45","author":"J Nezu","year":"1997","unstructured":"Nezu J, Oku A, Jones MH, Shimane M. Identification of two novel human putative serine\/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics. 1997;45(2):327\u201331.","journal-title":"Genomics"},{"issue":"5","key":"15804_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41423-021-00673-0","volume":"18","author":"WR He","year":"2021","unstructured":"He WR, Cao LB, Yang YL, Hua D, Hu MM, Shu HB. VRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release. Cell Mol Immunol. 2021;18(5):1186\u201396.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"15804_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.7150\/ijbs.66313","volume":"18","author":"J Chen","year":"2022","unstructured":"Chen J, Qiao K, Zhang C, Zhou X, Du Q, Deng Y, et al. VRK2 activates TNFalpha\/NF-kappaB signaling by phosphorylating IKKbeta in pancreatic cancer. Int J Biol Sci. 2022;18(3):1288\u2013302.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"15804_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-020-2724-5","volume":"11","author":"M Noguchi","year":"2020","unstructured":"Noguchi M, Hirata N, Tanaka T, Suizu F, Nakajima H, Chiorini JA. Autophagy as a modulator of cell death machinery. Cell Death Dis. 2020;11(7):517.","journal-title":"Cell Death Dis"},{"issue":"19","key":"15804_CR18","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1128\/MCB.01581-09","volume":"30","author":"IF Fernandez","year":"2010","unstructured":"Fernandez IF, Blanco S, Lozano J, Lazo PA. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer. Mol Cell Biol. 2010;30(19):4687\u201397.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"15804_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s12276-023-01060-7","volume":"55","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lin XT, Yu HQ, Fang L, Wu D, Luo YD, et al. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Exp Mol Med. 2023;55(10):2162\u201376.","journal-title":"Exp Mol Med"},{"issue":"Pt 10","key":"15804_CR20","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1099\/vir.0.81953-0","volume":"87","author":"LY Li","year":"2006","unstructured":"Li LY, Liu MY, Shih HM, Tsai CH, Chen JY. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. J Gen Virol. 2006;87(Pt 10):2869\u201378.","journal-title":"J Gen Virol"},{"issue":"16","key":"15804_CR21","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1158\/0008-5472.CAN-05-4399","volume":"66","author":"S Sengupta","year":"2006","unstructured":"Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 2006;66(16):7999\u20138006.","journal-title":"Cancer Res"},{"issue":"1","key":"15804_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13277-013-1022-6","volume":"35","author":"J Lan","year":"2014","unstructured":"Lan J, Huang HY, Lee SW, Chen TJ, Tai HC, Hsu HP, et al. TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma. Tumour Biol. 2014;35(1):179\u201387.","journal-title":"Tumour Biol"},{"issue":"8","key":"15804_CR23","doi-asserted-by":"publisher","first-page":"7983","DOI":"10.1007\/s13277-014-2065-z","volume":"35","author":"YE Lee","year":"2014","unstructured":"Lee YE, He HL, Lee SW, Chen TJ, Chang KY, Hsing CH, et al. AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma. Tumour Biol. 2014;35(8):7983\u201391.","journal-title":"Tumour Biol"},{"issue":"5","key":"15804_CR24","first-page":"912","volume":"7","author":"YE Lee","year":"2015","unstructured":"Lee YE, He HL, Chen TJ, Lee SW, Chang IW, Hsing CH, et al. The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area. Am J Transl Res. 2015;7(5):912\u201321.","journal-title":"Am J Transl Res"},{"issue":"12","key":"15804_CR25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.7150\/jca.15667","volume":"7","author":"YY Lee","year":"2016","unstructured":"Lee YY, Chao TB, Sheu MJ, Tian YF, Chen TJ, Lee SW, et al. Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma. J Cancer. 2016;7(12):1716\u201323.","journal-title":"J Cancer"},{"issue":"4","key":"15804_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/apm.13023","volume":"128","author":"SL Chang","year":"2020","unstructured":"Chang SL, Lee SW, Yang SF, Chien CC, Chan TC, Chen TJ, et al. Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma. APMIS. 2020;128(4):287\u201397.","journal-title":"APMIS"},{"issue":"4","key":"15804_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1200\/JCO.2001.19.4.1105","volume":"19","author":"SL Wolden","year":"2001","unstructured":"Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol. 2001;19(4):1105\u201310.","journal-title":"J Clin Oncol"},{"issue":"4","key":"15804_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","volume":"21","author":"JC Lin","year":"2003","unstructured":"Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003;21(4):631\u20137.","journal-title":"J Clin Oncol"},{"issue":"9","key":"15804_CR29","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1586\/era.10.97","volume":"10","author":"IW Tham","year":"2010","unstructured":"Tham IW, Lu JJ. Controversies and challenges in the current management of nasopharyngeal cancer. Expert Rev Anticancer Ther. 2010;10(9):1439\u201350.","journal-title":"Expert Rev Anticancer Ther"},{"key":"15804_CR30","first-page":"297","volume":"5","author":"DE Spratt","year":"2012","unstructured":"Spratt DE, Lee N. Current and emerging treatment options for nasopharyngeal carcinoma. Onco Targets Ther. 2012;5:297\u2013308.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"15804_CR31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.7150\/jca.11403","volume":"6","author":"XX Liang","year":"2015","unstructured":"Liang XX, Li Q, Su Z, Lan XW, Ouyang PY, Mao YP, et al. Significant prognostic impact of chemoradiotherapy-induced hemoglobin decrease on treatment outcomes of nasopharyngeal carcinoma. J Cancer. 2015;6(6):502\u201310.","journal-title":"J Cancer"},{"issue":"10022","key":"15804_CR32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012\u201324.","journal-title":"Lancet"},{"issue":"3","key":"15804_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","volume":"19","author":"XR Tang","year":"2018","unstructured":"Tang XR, Li YQ, Liang SB, Jiang W, Liu F, Ge WX, et al. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018;19(3):382\u201393.","journal-title":"Lancet Oncol"},{"issue":"2","key":"15804_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4448","volume":"235","author":"SW Tsao","year":"2015","unstructured":"Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235(2):323\u201333.","journal-title":"J Pathol"},{"issue":"12","key":"15804_CR35","first-page":"581","volume":"33","author":"LS Young","year":"2014","unstructured":"Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33(12):581\u201390.","journal-title":"Chin J Cancer"},{"issue":"2","key":"15804_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/path.4575","volume":"237","author":"AK Lo","year":"2015","unstructured":"Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. J Pathol. 2015;237(2):238\u201348.","journal-title":"J Pathol"},{"key":"15804_CR37","doi-asserted-by":"publisher","first-page":"840467","DOI":"10.3389\/fonc.2022.840467","volume":"12","author":"ZY Su","year":"2022","unstructured":"Su ZY, Siak PY, Leong CO, Cheah SC. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives. Front Oncol. 2022;12:840467.","journal-title":"Front Oncol"},{"issue":"20","key":"15804_CR38","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1128\/MCB.00025-07","volume":"27","author":"S Blanco","year":"2007","unstructured":"Blanco S, Santos C, Lazo PA. Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1. Mol Cell Biol. 2007;27(20):7273\u201383.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"15804_CR39","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1038\/cddis.2013.40","volume":"4","author":"DM Monsalve","year":"2013","unstructured":"Monsalve DM, Merced T, Fernandez IF, Blanco S, Vazquez-Cedeira M, Lazo PA. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression. Cell Death Dis. 2013;4(2):e513.","journal-title":"Cell Death Dis"},{"key":"15804_CR40","doi-asserted-by":"crossref","unstructured":"Ngan HL, Wang L, Lo KW, Lui VWY. Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer. Cancers (Basel). 2018;10(7):210.","DOI":"10.3390\/cancers10070210"},{"issue":"11","key":"15804_CR41","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/embor.2010.160","volume":"11","author":"H Gehart","year":"2010","unstructured":"Gehart H, Kumpf S, Ittner A, Ricci R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 2010;11(11):834\u201340.","journal-title":"EMBO Rep"},{"issue":"1","key":"15804_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/156652409787314507","volume":"9","author":"TH Page","year":"2009","unstructured":"Page TH, Smolinska M, Gillespie J, Urbaniak AM, Foxwell BM. Tyrosine kinases and inflammatory signalling. Curr Mol Med. 2009;9(1):69\u201385.","journal-title":"Curr Mol Med"},{"issue":"1","key":"15804_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/excr.2000.4839","volume":"256","author":"B Antonsson","year":"2000","unstructured":"Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res. 2000;256(1):50\u20137.","journal-title":"Exp Cell Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15804-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:04:39Z","timestamp":1776902679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15804"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15804-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Chi Mei Medical Center, Tainan, Taiwan (IRB No. IRB10501-006), and was conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived by the Institutional Review Board due to the retrospective nature of the study and the use of anonymized archived specimens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"512"}}